Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants.

Paul J. Martin(European Society for Blood and Marrow Transplantation), H. Joachim Deeg(University of Washington), John A. Hansen(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Keith M. Sullivan(National Cancer Institute), John O’Quigley, Jan‐Stephan Sanders(Tufts University), Donna Przepiorka(The University of Texas MD Anderson Cancer Center), Beverly Torok‐Storb(Fred Hutch Cancer Center), RP Witherspoon, Diane M. Durnam
PubMed
September 1, 1988
Cited by 195

Related Papers

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects
|Blood|2001|1.4k
Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy
|Blood|1997|1.2k